Delivery Order SPE2DB22D1017-SPE2DB24FF3XL

Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $1.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $13,953.86, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a completion date of February 27, 2024 and a potential value of $2,902.80. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 0.75 mg/0.5 ml pens. The $7,965.65 contract has an ultimate completion date of April 2, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $3,542.40, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. This $6,966.72 contract has an ultimate completion date of April 1, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $1,306.26 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $1,741.68 and a completion date of February 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $2,902.80 contract has an ultimate completion date of April 1, 2024. AmerisourceBergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceuticals. The delivery order has a potential value of $5,805.60 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also holds an...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $2,902.80 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. The company also holds an indefinite...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FF3XL
    Delivery Order

The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $1,863.36 contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025 to deliver a comprehensive range of medications and medical supplies to military treatment facilities worldwide. This IDC serves as the primary contract vehicle for Amerisourcebergen to support the Department of Defense. No set-aside designations were used for these contracts.

Generated 6/6/24, 9:06 AM